Etamicastat

Unknown Manufacturer

Etamicastat is under investigation in clinical trial NCT02840565 (Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453).

Generate AI report

Overview

Etamicastat is under investigation in clinical trial NCT02840565 (Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453).

Technical identifiers

Chemical Formula: C₁₄H₁₅F₂N₃OS
CAS Number: 760173-05-5
UNII ID: 9X96V6DBU4

Drugs